ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Gefitinib Plus Pemetrexed As First-Line Treatment in Patients With Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations.

Young Hak KimPubMed ↗Publisher ↗

No numbers read from the abstract.